Collaborative Study of 1,3 Butadiene Biomarkers
1 other identifier
observational
80
2 countries
2
Brief Summary
Butadiene is a suspect human carcinogen to which most people are exposed daily. Exposures are difficult to measure by air sampling. This study examines the relationship between air levels and several biomarkers of exposure. Biomarkers are substances analyzed in human tissues or waste products. Adducts are materials formed when a chemical reacts with a biological material. In this study we are looking at biomarkers in the blood: hemoglobin and DNA adducts, and urinary metabolites. If a strong relationship is found then the amounts of biomarkers in a person's blood or urine can tell us how much they have been exposed. The tests are being conducted on petrochemical workers who have a wide range of exposures to butadiene. An international group of investigators is conducting the study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 1999
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 1999
CompletedFirst Submitted
Initial submission to the registry
August 22, 2001
CompletedFirst Posted
Study publicly available on registry
August 24, 2001
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2002
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2002
CompletedApril 14, 2015
April 1, 2015
2.8 years
August 22, 2001
April 13, 2015
Conditions
Keywords
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
Study Sites (2)
Harvard School of Public Health
Boston, Massachusetts, 02115, United States
National Chung Kung University
Tainan, Taiwan
MeSH Terms
Conditions
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NIH
Study Record Dates
First Submitted
August 22, 2001
First Posted
August 24, 2001
Study Start
July 1, 1999
Primary Completion
May 1, 2002
Study Completion
June 1, 2002
Last Updated
April 14, 2015
Record last verified: 2015-04